ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1634

Genome-Wide Transcriptional Profiling Of Isolated Immune Cell Populations From SLE Patients With Different Ancestral Backgrounds

Shruti Sharma1, Zhongbo Jin2, Elizabeth Rosenzweig3, Swapna Rao4, Kichul Ko4 and Timothy B. Niewold2, 1Gwen Knapp Center for Lupus Research, University of Chicago, Chicago, IL, 2Division of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN, 3Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, IL, 4Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, IL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: genomics, Interferons and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus-Human Etiology and Pathogenesis: Genetics and Genomics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic lupus erythematosus (SLE) is a complex multi-system autoimmune disease of uncertain etiology.  Different ancestral backgrounds demonstrate different clinical manifestations and autoantibody profiles.  Whole blood gene expression studies in SLE have demonstrated a prominent type I interferon (IFN) signature.  Presumably different cell types will exhibit different patterns of gene expression, and in this study we sorted major immune cell populations from PBMC and examined genome-wide transcription patterns in cell subsets and in different ancestral backgrounds.

Methods: Peripheral blood was collected from 21 African-American (AA) and 21 European-American (EA) SLE patients, 5 AA controls, and 5 EA controls. CD4+ T-cells, CD8+ T-cells, monocytes and B cells were purified by flow sorting. Each cell population from each subject was run on an Illumina HumanHT-12 V4 expression BeadChip array. The raw data were filtered to exclude the non-detected genes. Quantile normalization and Log2 transformation were applied prior to between-group comparisons. Differentially expressed genes (DEGs) were determined by comparing cases and controls of the same ancestral background, and then DEG lists were compared between cell types and between ancestral backgrounds.  Because IFN-related gene expression differed between cell types, we also developed a novel metric to encompass IFN-induced gene expression more globally and comprehensively than pathway analyses, generating a quantitative metric. 

Results:   While we observed approximately 1000 DEGs in each cell type that was isolated, the overlap in DEG lists between different cell types was very modest (<1%), supporting the idea that different transcripts are upregulated in different cell types.  Typically between 5 to 10% of DEGs were shared when comparing the same cell type in different ancestral backgrounds (for ex. CD20 AA vs. CD20 EA).  Interestingly, gene expression profiles different cell types from the same subject exhibited individualized patterns on unsupervised hierarchical clustering, supporting some cell-type independent inter-individual variations.  Quantitative measurement of global IFN-induced gene expression revealed that AA subjects demonstrated more concordance across all studied cell types in IFN-induced gene expression.  In EA subjects, a subset of patients demonstrated increased IFN-induced gene expression in all lymphocyte populations but not monocytes, and another subgroup demonstrated IFN-induced gene expression in monocytes and B-cells but not in CD4 or CD8 T-cells.   

Conclusion: We find fascinating differences in gene expression between different immune cell populations and between ancestral backgrounds in SLE patients.  It seems that the IFN signature is relatively diverse, affecting different cell populations in different ways, and behaving differently in EA vs. AA patients.  These data may impact efforts to target this pathway therapeutically. 


Disclosure:

S. Sharma,
None;

Z. Jin,
None;

E. Rosenzweig,
None;

S. Rao,
None;

K. Ko,
None;

T. B. Niewold,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-transcriptional-profiling-of-isolated-immune-cell-populations-from-sle-patients-with-different-ancestral-backgrounds/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology